Faculty

Institution

Unit

Venue

Julio A. Camarero

John A Biles Professor in Pharmaceutical Sciences

University of Southern California

Affiliations

Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences

Department of Pharmacology and Pharmaceutical Sciences

Julio A. Camarero is currently serving as an Alfred E. Mann School Of Pharmacy And Pharmaceutical Sciences John A Biles Professor in Pharmaceutical Sciences at University of Southern California.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Julio A. Camarero

University of Southern California

John A Biles Professor in Pharmaceutical Sciences

You can click a keyword to filter the displayed items

biological engineering biomolecular engineering molecular biology protein science immunology protein engineering structural biology drug discovery medicinal chemistry virology biotechnology biosynthesis organic chemistry clinical microbiology peptide engineering foot-and-mouth disease virus recombinant expression peptides peptide science drug development protein synthesis pharmaceutical biotechnology protein ligation solid supports biotechnological applications virus research applied microbiology peptide synthesis protein chemistry molecular microbiology surface chemistry engineered cyclotide major antigenic site enzyme inhibition pharmacotherapy controlled release biological chemistry structural molecular biology molecular cancer clinical pharmacology pharmaceutical technology pharmaceutical sciences protein expression cancer treatment surface processing surface functionalization unprotected peptides bacterial cells backbone cyclization peptide-based therapeutics unnatural amino acids fluorescent cyclotides protein trans-splicing cyclotide-protein interactions cyclotide scaffold natural product research biomolecules oncogenes avian medicine peptide library tumor suppressors livestock health nanobiotechnology protein biosynthesis viral persistence innate immune system viral evolution protein purification antiviral compounds antiviral drugs antiviral therapy antiviral drug development pharmaceutical research bacteriology enzyme immobilization virus-host interactions peptide natural products bioorganic chemistry chemical biology

Notable Scholarly Works

Notable Federal Grants

Collaborators

Lipidation of a Bioactive Cyclotide-Based Cxcr4 Antagonist Greatly Improves Its Pharmacokinetic Profile in Vivo. Journal of Controlled Release (2023)

Dipankar ChaudhuriTiangong LuBinu JacobSojan AbrahamPremlata ShankarMichael A. PossNouri NeamatiJulio A. Camarero

pharmacologycontrolled releasepharmacokineticslipidspharmacokinetic profilebioactive compoundsdrug discovery

Resistance is Futile: Targeting Multidrug-Resistant Bacteria With De Novo Cys-Rich Cyclic Polypeptides. RSC Chemical Biology (2023)

Alvaro MourenzaRajasekaran GanesanJulio A. Camarero

antimicrobial resistancepharmacologyapplied microbiologyclinical microbiologymultidrug-resistant bacteriadrug resistance

Using the Cyclotide Scaffold for Targeting Biomolecular Interactions in Drug Development. Molecules (2022)

Binu JacobAlicia VogelaarEnrique CadenasJulio A. Camarero

biomolecular engineeringcyclotide scaffoldmolecular biologybiological engineeringdrug development

Chemical Synthesis of a Potent Antimicrobial Peptide Murepavadin Using a Tandem Native Chemical Ligation/Desulfurization Reaction. The Journal of Organic Chemistry (2021)

Dipankar ChaudhuriRajasekaran GanesanAlicia VogelaarMansour A. DughbajPaul M. BeringerJulio A. Camarero

medicinal chemistryantimicrobial agentsorganic chemistrypharmacologyantimicrobial compoundsorganic synthesisdrug discoverychemical synthesispeptide synthesis

Cover Feature: Engineered Cyclotides With Potent Broad in Vitro and in Vivo Antimicrobial Activity (Chem. Eur. J. 49/2021). Chemistry - A European Journal (2021)

Rajasekaran GanesanMansour A. DughbajLisa RamirezSteven BeringerTeshome L. AboyeAlexander ShekhtmanPaul M. BeringerJulio A. Camarero

pharmacologybiomedical engineeringbiotechnologychemistrycover feature

Engineered Cyclotides With Potent Broad in Vitro and in Vivo Antimicrobial Activity. Chemistry - A European Journal (2021)

Rajasekaran GanesanMansour A. DughbajLisa RamirezSteven BeringerTeshome L. AboyeAlexander ShekhtmanPaul M. BeringerJulio A. Camarero

medicinal chemistrybiomedical engineeringbiotechnologypharmaceutical biotechnologybiomolecular engineeringdrug discoverybiological engineering

Sars-Cov-2 Nsp5 Demonstrates Two Distinct Mechanisms Targeting Rig-I and Mavs to Evade the Innate Immune Response. mBio (2021)

Yongzhen LiuChao QinYouliang RaoChau NgoJoshua J. FengJun ZhaoShu ZhangTing-Yu WangJessica CarriereAli Can SavasMehrnaz ZarinfarStephanie RiceHanging YangWeiming YuanJulio A. CamareroJianhua YuXiaojiang S. ChenChao ZhangPinghui Feng

immunologyvirus researchsars-cov-2viral persistenceavian biologyinnate immune responseinnate immune systemvirologyviral evolution

Recombinant Expression of Cyclotides Using Expressed Protein Ligation. Methods in molecular biology (2020)

Maria Jose CampbellJingtan SuJulio A. Camarero

protein ligationrecombinant expressionmolecular biologyprotein engineeringbiological engineering

Abstract 4841: Rapid Screening of Cyclotide-Based Libraries for the Selection of Potent E3 Ligase Antagonists. Cancer Research (2019)

Julio A. Camarero

cyclotide-based librariescancer researchbiomolecular engineeringdrug discoverymedicinal researchrapid screeningcancer biology

Abstract A134: Therapeutic Targeting of Hdm2/Hdmx E3 Ligase With Bioactive Cyclotides. Molecular Cancer Therapeutics (2019)

Julio A Camarero

therapeutic targetingcancer researchmolecular cancermolecular biologybioactive cyclotidescancer treatment

1
2
3
4
5
11
10 / page

Julio A. Camarero

John A Biles Professor in Pharmaceutical Sciences

University of Southern California

Affiliations

Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences

Department of Pharmacology and Pharmaceutical Sciences

Julio A. Camarero is currently serving as an Alfred E. Mann School Of Pharmacy And Pharmaceutical Sciences John A Biles Professor in Pharmaceutical Sciences at University of Southern California.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Julio A. Camarero

University of Southern California

John A Biles Professor in Pharmaceutical Sciences

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Lipidation of a Bioactive Cyclotide-Based Cxcr4 Antagonist Greatly Improves Its Pharmacokinetic Profile in Vivo. Journal of Controlled Release (2023)

Dipankar ChaudhuriTiangong LuBinu JacobSojan AbrahamPremlata ShankarMichael A. PossNouri NeamatiJulio A. Camarero

pharmacologycontrolled releasepharmacokineticslipidspharmacokinetic profilebioactive compoundsdrug discovery

Resistance is Futile: Targeting Multidrug-Resistant Bacteria With De Novo Cys-Rich Cyclic Polypeptides. RSC Chemical Biology (2023)

Alvaro MourenzaRajasekaran GanesanJulio A. Camarero

antimicrobial resistancepharmacologyapplied microbiologyclinical microbiologymultidrug-resistant bacteriadrug resistance

Using the Cyclotide Scaffold for Targeting Biomolecular Interactions in Drug Development. Molecules (2022)

Binu JacobAlicia VogelaarEnrique CadenasJulio A. Camarero

biomolecular engineeringcyclotide scaffoldmolecular biologybiological engineeringdrug development

Chemical Synthesis of a Potent Antimicrobial Peptide Murepavadin Using a Tandem Native Chemical Ligation/Desulfurization Reaction. The Journal of Organic Chemistry (2021)

Dipankar ChaudhuriRajasekaran GanesanAlicia VogelaarMansour A. DughbajPaul M. BeringerJulio A. Camarero

medicinal chemistryantimicrobial agentsorganic chemistrypharmacologyantimicrobial compoundsorganic synthesisdrug discoverychemical synthesispeptide synthesis

Cover Feature: Engineered Cyclotides With Potent Broad in Vitro and in Vivo Antimicrobial Activity (Chem. Eur. J. 49/2021). Chemistry - A European Journal (2021)

Rajasekaran GanesanMansour A. DughbajLisa RamirezSteven BeringerTeshome L. AboyeAlexander ShekhtmanPaul M. BeringerJulio A. Camarero

pharmacologybiomedical engineeringbiotechnologychemistrycover feature

Engineered Cyclotides With Potent Broad in Vitro and in Vivo Antimicrobial Activity. Chemistry - A European Journal (2021)

Rajasekaran GanesanMansour A. DughbajLisa RamirezSteven BeringerTeshome L. AboyeAlexander ShekhtmanPaul M. BeringerJulio A. Camarero

medicinal chemistrybiomedical engineeringbiotechnologypharmaceutical biotechnologybiomolecular engineeringdrug discoverybiological engineering

Sars-Cov-2 Nsp5 Demonstrates Two Distinct Mechanisms Targeting Rig-I and Mavs to Evade the Innate Immune Response. mBio (2021)

immunologyvirus researchsars-cov-2viral persistenceavian biologyinnate immune responseinnate immune systemvirologyviral evolution

Recombinant Expression of Cyclotides Using Expressed Protein Ligation. Methods in molecular biology (2020)

Maria Jose CampbellJingtan SuJulio A. Camarero

protein ligationrecombinant expressionmolecular biologyprotein engineeringbiological engineering

Abstract 4841: Rapid Screening of Cyclotide-Based Libraries for the Selection of Potent E3 Ligase Antagonists. Cancer Research (2019)

Julio A. Camarero

cyclotide-based librariescancer researchbiomolecular engineeringdrug discoverymedicinal researchrapid screeningcancer biology

Abstract A134: Therapeutic Targeting of Hdm2/Hdmx E3 Ligase With Bioactive Cyclotides. Molecular Cancer Therapeutics (2019)

Julio A Camarero

therapeutic targetingcancer researchmolecular cancermolecular biologybioactive cyclotidescancer treatment

1
2
3
4
5
11
10 / page

Similar Faculty Members

Michael E Johnson

Institution

University of Illinois Chicago

molecular biology

biomolecular engineering

Bradley L. Pentelute

Institution

Massachusetts Institute of Technology

pharmacology

biomolecular engineering

Sylvie Garneau-Tsodikova

Institution

University of Kentucky

pharmacology

medicinal chemistry

Charles E. McKenna

Institution

University of Southern California

future medicinal chemistry

medicinal chemistry

Richard B. Silverman

Institution

Northwestern University

pharmacology

medicinal chemistry

Wenjun Zhang

Institution

University of California, Berkeley

natural product biosynthesis

natural product research

Dehua Pei

Institution

Ohio State University

intracellular biologics

organic chemistry

John Tomich

Institution

Kansas State University

synthetic biology

peptide

Thomas Kodadek

Institution

University of Florida

organic chemistry

bio-orthogonal chemistry

V. Jo Davisson

Institution

Purdue University

biochemistry

pharmacology

Similar Faculty Members

Michael E Johnson

Institution

University of Illinois Chicago

molecular biology

biomolecular engineering

Bradley L. Pentelute

Institution

Massachusetts Institute of Technology

pharmacology

biomolecular engineering

Sylvie Garneau-Tsodikova

Institution

University of Kentucky

pharmacology

medicinal chemistry

Charles E. McKenna

Institution

University of Southern California

future medicinal chemistry

medicinal chemistry

Richard B. Silverman

Institution

Northwestern University

pharmacology

medicinal chemistry

Wenjun Zhang

Institution

University of California, Berkeley

natural product biosynthesis

natural product research

Dehua Pei

Institution

Ohio State University

intracellular biologics

organic chemistry

John Tomich

Institution

Kansas State University

synthetic biology

peptide

Thomas Kodadek

Institution

University of Florida

organic chemistry

bio-orthogonal chemistry

V. Jo Davisson

Institution

Purdue University

biochemistry

pharmacology